The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I’ve taken a few today too. I know it’s currently being actively promoted by a few accounts including Burton, normally I avoid, but in this case I think it’s a decent entry point and worth a punt.
Thanks guys..took a decent initial lot today for my dividend pot. Very attractive annual divvy amount at these prices.
Might get even more attractive if price drops further with general market ups and downs and issues in Kazakhstan.